Patents by Inventor Michael Zenilman

Michael Zenilman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated PAP2 and methods of making and using same
    Patent number: 8012928
    Abstract: A method of treating pancreatitis is provided, including the steps of: providing a mammal having pancreatitis; and administering a therapeutically effective amount of a truncated N-terminal PAP2; and making of an antibody specifically directed to detect PAP2.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: September 6, 2011
    Assignee: The Research Foundation of State University of New York
    Inventors: Martin H. Bluth, Michael Zenilman
  • TRUNCATED PAP2 AND METHODS OF MAKING AND USING SAME
    Publication number: 20100158809
    Abstract: A method of treating pancreatitis is provided, including the steps of: providing a mammal having pancreatitis; and administering a therapeutically effective amount of a truncated N-terminal PAP2; and making of an antibody specifically directed to detect PAP2.
    Type: Application
    Filed: December 18, 2009
    Publication date: June 24, 2010
    Applicant: The Research Foundation of State University of New York
    Inventors: Martin H. Bluth, Michael Zenilman
  • PANCREATIC REGENERATING PROTEIN I IN CHRONIC PANCREATITIS AND AGING IMPLICATIONS FOR NEW THERAPEUTIC APPROACHES TO DIABETES
    Publication number: 20100099615
    Abstract: The present invention provides a method of treating diabetes, including administering to a mammal diagnosed with diabetes a purified recombinant reg I protein.
    Type: Application
    Filed: October 15, 2009
    Publication date: April 22, 2010
    Applicant: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    Inventors: Martin H. Bluth, Michael Zenilman